Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2025 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z.
J Hematol Oncol. 2022.
PMID: 35982483
Free PMC article.
Clinical Trial.
[Comparison of BCR::ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic myeloid leukemia].
Gao HL, Hao Y, Chen WM, Li LD, Wang X, Qin YZ, Jiang Q.
Gao HL, et al.
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):906-910. doi: 10.3760/cma.j.issn.0253-2727.2023.11.004.
Zhonghua Xue Ye Xue Za Zhi. 2023.
PMID: 38185519
Free PMC article.
Chinese.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.